These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29699348)

  • 41. Adipokines and C-reactive protein in relation to bone mineralization in pediatric nonalcoholic fatty liver disease.
    Pacifico L; Bezzi M; Lombardo CV; Romaggioli S; Ferraro F; Bascetta S; Chiesa C
    World J Gastroenterol; 2013 Jul; 19(25):4007-14. PubMed ID: 23840146
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Eslami L; Merat S; Malekzadeh R; Nasseri-Moghaddam S; Aramin H
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008623. PubMed ID: 24374462
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cytokeratin 18, alanine aminotransferase, platelets and triglycerides predict the presence of nonalcoholic steatohepatitis.
    Cao W; Zhao C; Shen C; Wang Y
    PLoS One; 2013; 8(12):e82092. PubMed ID: 24324749
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatic steatosis in obese Chinese children.
    Chan DF; Li AM; Chu WC; Chan MH; Wong EM; Liu EK; Chan IH; Yin J; Lam CW; Fok TF; Nelson EA
    Int J Obes Relat Metab Disord; 2004 Oct; 28(10):1257-63. PubMed ID: 15278103
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gamma-glutamyl transpeptidase elevation is associated with metabolic syndrome, hepatic steatosis, and fibrosis in patients with nonalcoholic fatty liver disease: A community-based cross-sectional study.
    Chen LW; Huang MS; Shyu YC; Chien RN
    Kaohsiung J Med Sci; 2021 Sep; 37(9):819-827. PubMed ID: 34002481
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Non-invasive Diagnosis of Fibrosis in Non-alcoholic Fatty Liver Disease.
    Arora A; Sharma P
    J Clin Exp Hepatol; 2012 Jun; 2(2):145-55. PubMed ID: 25755423
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors.
    Leite NC; Villela-Nogueira CA; Pannain VL; Bottino AC; Rezende GF; Cardoso CR; Salles GF
    Liver Int; 2011 May; 31(5):700-6. PubMed ID: 21457442
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reduced Glutathione suppresses Oxidative Stress in Nonalcoholic Fatty Liver Disease.
    Irie M; Sohda T; Anan A; Fukunaga A; Takata K; Tanaka T; Yokoyama K; Morihara D; Takeyama Y; Shakado S; Sakisaka S
    Euroasian J Hepatogastroenterol; 2016; 6(1):13-18. PubMed ID: 29201718
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ultrasonographic index for the diagnosis of non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease.
    Kim JW; Lee CH; Kim BH; Lee YS; Hwang SY; Park BN; Park YS
    Quant Imaging Med Surg; 2022 Mar; 12(3):1815-1829. PubMed ID: 35284276
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Probiotic Therapy in Patients with Nonalcoholic Steatohepatitis in Zagazig University Hospitals.
    Abdel Monem SM
    Euroasian J Hepatogastroenterol; 2017; 7(1):101-106. PubMed ID: 29201787
    [TBL] [Abstract][Full Text] [Related]  

  • 52.
    Lisboa QC; Nardelli MJ; Pereira PA; Miranda DM; Ribeiro SN; Costa RSN; Versiani CA; Vidigal PVT; Ferrari TCA; Couto CA
    World J Hepatol; 2020 Oct; 12(10):792-806. PubMed ID: 33200017
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Features of nonalcoholic steatohepatitis in severely obese children and adolescents undergoing sleeve gastrectomy.
    Alqahtani A; Elahmedi M; Alswat K; Arafah M; Fagih M; Lee J
    Surg Obes Relat Dis; 2017 Sep; 13(9):1599-1609. PubMed ID: 28600116
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease.
    Sorbi D; Boynton J; Lindor KD
    Am J Gastroenterol; 1999 Apr; 94(4):1018-22. PubMed ID: 10201476
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ultrasonography as a non-invasive tool for detection of nonalcoholic fatty liver disease in overweight/obese Egyptian children.
    El-Koofy N; El-Karaksy H; El-Akel W; Helmy H; Anwar G; El-Sayed R; El-Hennawy A
    Eur J Radiol; 2012 Nov; 81(11):3120-3. PubMed ID: 22817846
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.
    Tsochatzis E; Papatheodoridis GV; Hadziyannis E; Georgiou A; Kafiri G; Tiniakos DG; Manesis EK; Archimandritis AJ
    Scand J Gastroenterol; 2008; 43(9):1128-36. PubMed ID: 18609175
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Histological Evaluation of Non-alcoholic Fatty Liver Disease and Its Correlation with Different Noninvasive Scoring Systems with Special Reference to Fibrosis: A Single Center Experience.
    Rath MM; Panigrahi MK; Pattnaik K; Bhuyan P; Kar SK; Misra B; Misra D; Meher C; Agrawal O; Rath J; Singh SP
    J Clin Exp Hepatol; 2016 Dec; 6(4):291-296. PubMed ID: 28003718
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Non-Alcoholic Fatty Liver Disease, an Overview.
    Nd AM
    Integr Med (Encinitas); 2019 Apr; 18(2):42-49. PubMed ID: 31341444
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum cytokeratin 18 fragment level as a noninvasive biomarker for non-alcoholic fatty liver disease.
    Aida Y; Abe H; Tomita Y; Nagano T; Seki N; Sugita T; Itagaki M; Ishiguro H; Sutoh S; Aizawa Y
    Int J Clin Exp Med; 2014; 7(11):4191-8. PubMed ID: 25550930
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictors of nonalcoholic steatohepatitis in patients with elevated alanine aminotransferase activity.
    Puljiz Z; Stimac D; Kovac D; Puljiz M; Bratanić A; Kovacić V; Kardum D; Bonacin D; Hozo I
    Coll Antropol; 2010 Mar; 34 Suppl 1():33-7. PubMed ID: 20402293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.